Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Singular Health Group Ltd ( (AU:SHG) ) just unveiled an announcement.
Singular Health Group Ltd has made significant strides in its U.S. market expansion during the September 2025 quarter, marked by the deployment of 250 licenses of its 3DICOM™ MD product under a contract with Provider Network Solution (PNS). The company anticipates substantial cost savings for PNS and is poised for further contract expansion. Additionally, Singular Health is engaging with major U.S. healthcare organizations and federal agencies to integrate its solutions into broader healthcare programs, supported by a strong financial position and the establishment of a U.S. subsidiary.
The most recent analyst rating on (AU:SHG) stock is a Sell with a A$0.50 price target. To see the full list of analyst forecasts on Singular Health Group Ltd stock, see the AU:SHG Stock Forecast page.
More about Singular Health Group Ltd
Singular Health Group Ltd operates in the medical imaging industry, focusing on providing interoperable imaging solutions. Their primary product, 3DICOM™, is designed for imaging aggregation and AI development. The company is expanding its presence in the U.S. healthcare market and is involved in collaborations with healthcare organizations and federal agencies to improve imaging efficiency and access.
Average Trading Volume: 938,530
Technical Sentiment Signal: Buy
Current Market Cap: A$93.77M
Find detailed analytics on SHG stock on TipRanks’ Stock Analysis page.